Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/dTAQCfbwoceNoQjlHuDG

  ADVERTISEMENT  
October 8, 2012
Sign upForwardArchiveAdvertise
News for nurse practitioners

  Health Care News 
 
  • Meningitis cases in U.S. reach 91
    The total number of reported fungal meningitis cases has reached 91, including seven deaths, CDC officials reported Sunday. Nine states have been affected. Federal and state officials are investigating New England Compounding Center's facility in Framingham, Mass., which made the spinal steroid injections linked to the outbreak. The company has recalled all products made at the facility, and last week federal officials advised against using NECC-manufactured products. Reuters (10/7), The Wall Street Journal (10/7) LinkedInFacebookTwitterEmail this Story
  • Stress ups risk of death in heart attack patients, study finds
    Researchers tracked 4,200 heart attack patients in the U.S. and found that those who reported the most stress had a 42% greater risk of death over the next two years. Just under 9% percent of patients who reported less than moderate stress died during the study period compared with 13% of patients who reported moderate to high stress. The study was published in the Journal of the American College of Cardiology. Reuters (10/5) LinkedInFacebookTwitterEmail this Story
  • Severe anemia is linked to poor outcomes after heart surgery
    Adults with severe anemia were more likely to die or suffer a stroke after heart surgery than patients without the condition, Italian researchers reported in The Annals of Thoracic Surgery. Severe anemia also is associated with prolonged mechanical ventilation and longer ICU stays after surgery. The study supports the addition of severe anemia to the list of risk factors for heart surgery complications, according to an accompanying commentary. HealthDay News (10/4) LinkedInFacebookTwitterEmail this Story
  • Obesity cuts death risk, raises other complications in RA patients
    Obese and overweight rheumatoid arthritis patients had a 20% reduced risk of death from heart problems and from all causes compared with normal-weight patients with rheumatoid arthritis, an analysis of data about 24,535 people found. Obese patients, however, also were more likely to have a heart attack, need a joint replacement, and develop diabetes, hypertension or a work disability. The findings appeared in the journal Arthritis Care & Research. DailyRx.com (10/7) LinkedInFacebookTwitterEmail this Story
 
  • More work needed for managing pediatric heart risks, study says
    A study of 963 well-child checks found most included records of body mass index and blood pressure, but none of the charts had interpretations of blood pressure results or recommendations for management. Researchers also found that only 30% of the charts included recommendations for managing children with an elevated BMI. The study was presented at the Obesity Society meeting. Family Practice News (10/4) LinkedInFacebookTwitterEmail this Story
  ADVERTISEMENT  
Guide to Reimbursement for Care Plan Oversight
Medicare reimburses physicians, NPs and PAs for time spent overseeing the care of patients receiving home care services. You may already be doing the work, why not get paid for it? This free guide to Care Plan Oversight gives you the conditions of coverage, billing tips and local reimbursement rates for many markets nationwide.
  Pharmaceutical News 
 
  • Vytorin shows cholesterol benefits in diabetes regardless of weight
    Vytorin treatment is effective in lowering cholesterol levels in diabetes patients whether they were obese or not, researchers reported at the European Association for the Study of Diabetes meeting. Researchers said Vytorin enabled 52.2% of obese and 57.4% of non-obese patients to reach their target LDL cholesterol levels and 62.2% of obese patients and 63.2% of non-obese patients to reach their non-HDL cholesterol goals. MedPage Today (free registration) (10/4) LinkedInFacebookTwitterEmail this Story
  • Study links weight-loss drug to better HbA1C levels
    Type 2 diabetes patients who took the weight-loss drug Qsymia attained a 0.4% mean reduction in HbA1C, compared with only 0.1% in the placebo group, an analysis of data from the CONQUER trial showed. Another review of the trial data found fewer patients on Qsymia treatment needed to increase their diabetes medication intake during the 56-week study. The findings were presented at the European Association for the Study of Diabetes meeting. MedPage Today (free registration) (10/6) LinkedInFacebookTwitterEmail this Story
  ADVERTISEMENT  
It's that time of year again,
when more than 20,000 Lilly employees will be out of the office helping friends and neighbors in communities around the world. Since 2008, we have given nearly 500,000 volunteer hours through our Global Day of Service. Learn how we're making a difference at lillyGDOS.com.
  Hot Topics 

Top five news stories selected by AANP SmartBrief readers in the past week.

  • Results based on number of times each story was clicked by readers.
  Emerging Trends, Products and Technologies 
 
  • Meatless Monday can change eating habits, survey finds
    An online survey by FGI Research found the Meatless Monday campaign has led 73% of people to eat more vegetables, 64% to consume more fruit and 47% to add more whole grains to their diet. Half of survey respondents said they experiment with meatless recipes at home, and 42% say they now try more meatless dishes at restaurants. United Press International (10/4) LinkedInFacebookTwitterEmail this Story
We’re out to change the way the world looks at medical malpractice insurance.
By harnessing data and leveraging analytics, we're able to put our business intelligence, proven risk reduction strategies and innovative educational programs to work, so that you can anticipate risk and improve overall outcomes. Learn more
Advertisement

  Health Policy and Legislative News 
  AANP News 
  • AANP and ACNP breaking news!
    The boards of directors of the AANP and the American College of Nurse Practitioners have approved the terms of the agreement for merging the two organizations, and we are thrilled to be able to share this news with you. Pending approval by AANP membership, this consolidation has the ability to further empower the NP community as we continue to shape and direct policy and legislative priorities, and operate from a position of greater strength, unity and visibility. More information is available to members. LinkedInFacebookTwitterEmail this Story
  • Presidential proclamation -- Breast Cancer Awareness Month
    Breast cancer touches the lives of Americans from every background and in every community across our nation. Though great strides have been made in combating this devastating illness, more than 200,000 women will be diagnosed with breast cancer this year, and tens of thousands are expected to lose their lives to the disease. During National Breast Cancer Awareness Month in October, we honor those we have lost, lend our strength to those who carry on the fight, and pledge to educate ourselves and our loved ones about this tragic disease. AANP members: Let us know about any special initiatives you are undertaking in your communities to promote breast cancer awareness month. Contact editor@aanp.org. Read the presidential proclamation. LinkedInFacebookTwitterEmail this Story
Learn more about AANP ->Home Page | Join AANP | Legislation/Practice | CareerLink

  SmartQuote 
The ability to deal with people is as purchasable a commodity as sugar or coffee and I will pay more for that ability than for any other under the sun."
--John D. Rockefeller,
American industrialist and philanthropist


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

Advertise
Account Director:  Aaron Kern (202) 407-7866
 
Read more at SmartBrief.com
A powerful website for SmartBrief readers including:
 
 
 Recent AANP SmartBrief Issues:   Lead Editor:  Tom Parks
     
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2012 SmartBrief, Inc.® Legal Information